A detailed history of Group One Trading, L.P. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 19,044 shares of ANIX stock, worth $51,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,044
Holding current value
$51,228
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.21 - $3.48 $42,087 - $66,273
19,044 New
19,044 $59,000
Q4 2023

Feb 14, 2024

SELL
$2.85 - $4.19 $889 - $1,307
-312 Reduced 19.54%
1,285 $4,000
Q3 2023

Nov 09, 2023

SELL
$2.97 - $3.87 $12,987 - $16,923
-4,373 Reduced 73.25%
1,597 $5,000
Q2 2023

Aug 09, 2023

BUY
$3.0 - $5.97 $17,910 - $35,640
5,970 New
5,970 $19,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $82.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.